Skip to main content

This website is intended exclusively for healthcare professionals residing and/or working in the UAE.

Home | go to homepage
SCIENCE
  • SCIENCE
  • Allergic Rhinitis
  • Anti-Infectives
  • Asthma
  • Atopic Dermatitis
  • Cardiovascular
    • Cardiovascular
    • Atherothrombosis
    • Dyslipidemia
    • Thrombosis
  • Diabetes
  • Eosinophilic Esophagitis
  • Microbiota and Probiotics
  • Oncology and Rare Blood Disorder
    • Oncology and Rare Blood Disorder
    • Multiple Myeloma
  • Multiple Sclerosis
  • Nasal Polyps
  • Neurological Disorders
  • Prurigo Nodularis
  • Rare Diseases
  • Vaccines
    • Vaccines
    • Influenza
    • Meningitis
    • Pertussis & Polio
    • RSV
PATIENT SUPPORT
  • PATIENT SUPPORT
  • Allergic Rhinitis
  • Atopic Dermatitis
  • Cardiovascular
  • Diabetes
    • Diabetes
    • Tools And Resources
      • Tools And Resources
      • Pre-Ramadan Assessment Tools
      • Toujeo Welcome Pack
      • Soliqua Welcome Pack
      • Clinical and economic value of SOLIQUA - Pharmacist perspective
  • Nasal Polyps
  • Rare Diseases
PRODUCTS
  • PRODUCTS
  • Aldurazyme®
    • Aldurazyme®
    • Dosing Calculator
  • Amaryl®
  • Apidra®
  • Aprovel®
  • Aubagio®
    • Aubagio®
    • Aubagio vs Ofatumumab
  • Cerezyme
  • Clexane®
  • Depakine®
  • Dupixent®
    • Dupixent®
    • Asthma
    • Atopic Dermatitis
    • Nasal Polyps
    • Dupixent Eosinophilic Esophagitis
    • Prurigo Nodularis
  • Lantus®
  • Lemtrada®
  • Plavix®
  • Praluent®
    • Praluent®
    • Praluent®
    • Praluent 300 mg
  • Sarclisa
    • Sarclisa
    • Sarclisa®
    • Sarclisa Kd®
    • Sarclisa Pd®
  • Soliqua®
    • Soliqua®
    • For a Peaceful Ramadan
    • SoliMix Study
    • Soli-Simplify Study
    • Soliqua®
    • Soliqua Safety®
    • Soliqua Simplicity®
    • Soliqua Data Set®
    • Soliqua Guidelines®
  • Solian
  • Tavanic®
  • Toujeo®
    • Toujeo®
    • Toujeo®
    • For a Peaceful Ramadan
    • Time-in-Range
    • Real world Evidences
  • Xenpozyme®
    • Xenpozyme®
    • Dose Escalation Phase of Olipudase
  • Zympass®
  • Xatral®
EVENTS
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
  • LOGIN
  • SIGN UP
  • SEARCH
    Home | go to homepage
    SCIENCE
    • SCIENCE
    • Allergic Rhinitis
    • Anti-Infectives
    • Asthma
    • Atopic Dermatitis
    • Cardiovascular
      • Cardiovascular
      • Atherothrombosis
      • Dyslipidemia
      • Thrombosis
    • Diabetes
    • Eosinophilic Esophagitis
    • Microbiota and Probiotics
    • Oncology and Rare Blood Disorder
      • Oncology and Rare Blood Disorder
      • Multiple Myeloma
    • Multiple Sclerosis
    • Nasal Polyps
    • Neurological Disorders
    • Prurigo Nodularis
    • Rare Diseases
    • Vaccines
      • Vaccines
      • Influenza
      • Meningitis
      • Pertussis & Polio
      • RSV
    PATIENT SUPPORT
    • PATIENT SUPPORT
    • Allergic Rhinitis
    • Atopic Dermatitis
    • Cardiovascular
    • Diabetes
      • Diabetes
      • Tools And Resources
        • Tools And Resources
        • Pre-Ramadan Assessment Tools
        • Toujeo Welcome Pack
        • Soliqua Welcome Pack
        • Clinical and economic value of SOLIQUA - Pharmacist perspective
    • Nasal Polyps
    • Rare Diseases
    PRODUCTS
    • PRODUCTS
    • Aldurazyme®
      • Aldurazyme®
      • Dosing Calculator
    • Amaryl®
    • Apidra®
    • Aprovel®
    • Aubagio®
      • Aubagio®
      • Aubagio vs Ofatumumab
    • Cerezyme
    • Clexane®
    • Depakine®
    • Dupixent®
      • Dupixent®
      • Asthma
      • Atopic Dermatitis
      • Nasal Polyps
      • Dupixent Eosinophilic Esophagitis
      • Prurigo Nodularis
    • Lantus®
    • Lemtrada®
    • Plavix®
    • Praluent®
      • Praluent®
      • Praluent®
      • Praluent 300 mg
    • Sarclisa
      • Sarclisa
      • Sarclisa®
      • Sarclisa Kd®
      • Sarclisa Pd®
    • Soliqua®
      • Soliqua®
      • For a Peaceful Ramadan
      • SoliMix Study
      • Soli-Simplify Study
      • Soliqua®
      • Soliqua Safety®
      • Soliqua Simplicity®
      • Soliqua Data Set®
      • Soliqua Guidelines®
    • Solian
    • Tavanic®
    • Toujeo®
      • Toujeo®
      • Toujeo®
      • For a Peaceful Ramadan
      • Time-in-Range
      • Real world Evidences
    • Xenpozyme®
      • Xenpozyme®
      • Dose Escalation Phase of Olipudase
    • Zympass®
    • Xatral®
    EVENTS
  • LOGIN
  • SIGN UP
  • SEARCH
    • Home
    • Science
    • Cutting-Edge Science

    Science at Sanofi

    Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

    Filters

    Therapeutical Areas
    Dyslipidemia
    Thrombosis
    Atherothrombosis
    Diabetes
    Asthma
    Atopic Dermatitis
    Nasal Polyps
    Vaccines
    Influenza
    Rare diseases
    Neurological Disorders
    Multiple sclerosis
    Pertussis & Polio
    Meningitis
    Prurigo Nodularis
    Oncology and Rare Blood Disorder
    Eosinophilic Esophagitis
    Allergic Rhinitis
    Type of Content
    Watch
    Listen
    Read

    Diagnostic Algorithm for Gaucher Disease in Pediatric

    Bone Monitoring Guidelines in Gaucher Disease Video

    Diagnostic Algorithm for Gaucher Disease in Adult

    Living with Pompe Disease series is live on Youtube Juan's story

    Professor Tawfeq Ben Omran video on ASMD

    Professor Fatma Al-Jasmi video on ASMD

    Professor Moeen Al Sayed video on ASMD

    MPSI chase the signs video

    Epilepsy Do’s and Don’ts

    Early diagnosis and management of IOPD

    Diagnostic challenges of LOPD

    New 2022 ADA/EASD Guidelines: GLPP-1 RA/Insulin combination is very high recommended

    ⇤
    ←
    ...
    ←
    1
    2
    3
    4
    5
    1
    2
    3
    4
    5
    ...
    →
    →
    ⇥
    Home | go to homepage

    SANOFI, Level 3, One JLT, Jumeirah Lake Towers (JLT), DMCC, PO Box 53899, Dubai, UAE | Tel.: +971 4 550 3600 | Fax: +971 4 5521050

    For further Medical Information: please contact: 800 MEDICAL Toll-Free Number,

    Email: medical-information.gulf@sanofi.com

    To report an adverse event: please call: +971 561747001 or

    Email: Gulf.pharmacovigilance@sanofi.com

    To report any product technical complaints, kindly contact:

    Email: quality.greatergulf@sanofi.com

    MAT-AE-2100444-V5-May-23

    • Legal notice
    • Cookie policy
    • Privacy policy
    • Sitemap
    • Change country

    YOU WILL NOW BE LEAVING THE SITE

    By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
    Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.

    Continue
    This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
     
    Please choose if you are a healthcare professional and wish to continue on this site or if you are a member of the public to be redirected to the Sanofi website.